434 filings
Page 5 of 22
8-K
7vd2a7j
26 Oct 12
Conference Call and Webcast
12:00am
8-K
8s0kx2yrimuq
22 Oct 12
Other Events
12:00am
8-K
jqd0fz8zshhjjd cf
7 Sep 12
Fda Continues Review of Crofelemer New Drug
12:00am
8-K
0dngpjo2
10 Aug 12
Salix Pharmaceuticals And Alfa Wassermann Announce License Agreement For A New Extended Intestinal Release Formulation Of Rifaximin
12:00am
8-K
ui7eo4y3677m0eelig
8 Aug 12
Results of Operations and Financial Condition
12:00am
8-K
cksuqh8uw6
31 Jul 12
Conference Call and Webcast
12:00am
8-K
2qez9rpjz7d90j3y 3e0
20 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
66zzmba
31 May 12
Other Events
12:00am
8-K
8rxip
16 May 12
Departure of Directors or Certain Officers
12:00am
8-K
qaaffg622ojvev2
7 May 12
Results of Operations and Financial Condition
12:00am
8-K
1mw76lx7v0p7eq
2 May 12
Other Events
12:00am
8-K
0hle7ks 1e0b351pl
24 Apr 12
Conference Call and Webcast
12:00am
8-K
yp0x7y3vunky wfdqn
16 Mar 12
Entry into a Material Definitive Agreement
12:00am
8-K
ph1gfg1 v1unoy
13 Mar 12
Salix Pharmaceuticals Prices Convertible Notes Offering
12:00am
8-K
2y79gj3j9
12 Mar 12
Salix Pharmaceuticals Announces Proposed
12:00am
8-K
6rlvw8gx6 7h
2 Mar 12
Other Events
12:00am
8-K/A
7ef0qx40n4rq
28 Feb 12
With Report of Independent Auditors
12:00am
8-K
7vjrs msvs1wdsgb
27 Feb 12
4Q and FY2011 Results
12:00am
8-K
kiy owuvi21e9xzwgh71
22 Feb 12
Other Events
12:00am
8-K
wywj8as
14 Feb 12
4Q2011 and FY2011 Financial Results
12:00am